Ondine Biomedical, a global leader in light-activated antimicrobial technologies, is pleased to announce that patient recruitment has commenced in an intensive care unit (ICU) pilot study at Royal ...

Procedures of Reevaluation of the SOP ... All patients admitted to the ICU who were treated with at least two different i.v. drugs were included. In this study, the effect of SOP implementation ...

Medical device company ICU Medical (NASDAQ:ICUI) reported Q4 CY2024 results , with sales up 7.1% year ... and technological advancements like minimally invasive procedures and connected devices that ...